
Drew Weissman MD
Associate Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3900 Woodland AvePhiladelphia, PA 19104
Phone+1 215-823-5800
Dr. Weissman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1990 - 1993
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
- Boston University School of MedicineClass of 1987
Certifications & Licensure
- PA State Medical License 1997 - 2026
- MD State Medical License 1990 - 1997
Publications & Presentations
PubMed
- Tick feeding or vaccination with tick antigens elicits immunity to theexoproteome in guinea pigs and humans.Thomas M Hart, Yingjun Cui, Sam R Telford, Alejandro Marín-López, Keith Calloway
Science Translational Medicine. 2025-03-26 - CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery.Tyler Ellis Papp, Jianhao Zeng, Hamna Shahnawaz, Awurama Akyianu, Laura Breda
Molecular Therapy. 2025-03-13 - Restoring hematopoietic stem and progenitor cell function inmice bydelivery of RNA lipid nanoparticles.Omar Banda, Sarah E Adams, Linah Omer, Seul K Jung, Hooda Said
Molecular Therapy. Nucleic Acids. 2025-03-11
Press Mentions
- Why Is Philadelphia Called the Cellicon Valley?April 1st, 2025
- New Technology Is Poised to Bring Gene Therapy to Common Chronic DiseasesMarch 25th, 2025
- Remembrance and Resilience at Penn Medicine Five Years After COVID-19March 4th, 2025
- Join now to see all
Grant Support
- Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
- Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
- Cardiac delivery of RNA to treat contractile disorderUNIVERSITY OF PENNSYLVANIA2024–2028
- mVACS--mRNA Vaccines for C. difficile SuppressionUNIVERSITY OF PENNSYLVANIA2023–2028
- Vascular Targeting of Nanocarriers for RNAUNIVERSITY OF PENNSYLVANIA2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: